Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
51
TKR Quote, Financials, Valuation and Earnings
Last price:
$74.26
Seasonality move
:
6.4%
Day range:
$73.02 - $74.42
52-week range:
$69.35 - $94.71
Dividend yield:
1.83%
P/E ratio:
14.87x
P/S ratio:
1.15x
P/B ratio:
1.84x
Volume:
1.1M
Avg. volume:
613.2K
1-year change:
-16.89%
Market cap:
$5.2B
Revenue:
$4.6B
EPS (TTM):
$4.99
Analysts' Opinion
-
Consensus RatingThe Timken has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $91.20, The Timken has an estimated upside of 22.94% from its current price of $74.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $77.00 representing 100% downside risk from its current price of $74.18.
Fair Value
-
According to the consensus of 11 analysts, The Timken has 22.94% upside to fair value with a price target of $91.20 per share.
TKR vs. S&P 500
-
Over the past 5 trading days, The Timken has underperformed the S&P 500 by -0.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Timken does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Timken revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter The Timken reported revenues of $1.1B.
Earnings Growth
-
The Timken has grown year-over-year earnings for 1 quarter straight. In the most recent quarter The Timken reported earnings per share of $1.01.
Enterprise value:
7.1B
EV / Invested capital:
1.40x
Price / LTM sales:
1.15x
EV / EBIT:
11.39x
EV / Revenue:
1.54x
PEG ratio (5yr expected):
--
EV / Free cash flow:
23.07x
Price / Operating cash flow:
17.17x
Enterprise value / EBITDA:
8.39x
Gross Profit (TTM):
$1.4B
Return On Assets:
5.37%
Net Income Margin (TTM):
7.71%
Return On Equity:
12.19%
Return On Invested Capital:
6.85%
Operating Margin:
11.02%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4.5B | $4.8B | $4.6B | $1.1B | $1.1B | |
| Gross Profit | $1.3B | $1.5B | $1.4B | $331.3M | $325.1M | |
| Operating Income | $651M | $702.6M | $610.7M | $124.4M | $118.3M | |
| EBITDA | $789.5M | $842.5M | $841.1M | $144.6M | $175M | |
| Diluted EPS | $5.48 | $5.46 | $4.99 | $0.83 | $1.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $2.2B | $2.5B | $2.6B | $2.5B | |
| Total Assets | $5B | $5.2B | $5.8B | $6.5B | $6.4B | |
| Current Liabilities | $848M | $896.6M | $1B | $1.5B | $820.5M | |
| Total Liabilities | $2.8B | $2.8B | $3.4B | $3.8B | $3.4B | |
| Total Equity | $2.2B | $2.4B | $2.4B | $2.7B | $3B | |
| Total Debt | $1.6B | $1.5B | $2B | $2.4B | $2.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $463.8M | $545.2M | $475.7M | $128.3M | $178.6M | |
| Cash From Investing | -$573.3M | -$806.5M | -$304.6M | -$207.4M | -$54.6M | |
| Cash From Financing | $206.8M | $347.1M | -$194.8M | $111.5M | -$140.6M | |
| Free Cash Flow | $285.4M | $357.4M | $305.7M | $75.4M | $125M | |
TKR
Sector
Market Cap
$5.2B
$618.1M
Price % of 52-Week High
78.33%
74.1%
Dividend Yield
1.83%
0%
Shareholder Yield
-1.4%
2.42%
1-Year Price Total Return
-16.9%
-6.88%
Beta (5-Year)
1.374
0.889
Dividend yield:
1.83%
Annualized payout:
$1.35
Payout ratio:
27.25%
Growth streak:
11 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$74.34
200-day SMA
Sell
Level
$79.89
Bollinger Bands (100)
Sell
Level
73.32 - 80.98
Chaikin Money Flow
Buy
Level
113.2M
20-day SMA
Sell
Level
$76.81
Relative Strength Index (RSI14)
Sell
Level
41.04
ADX Line
Sell
Level
23.82
Williams %R
Neutral
Level
-61.1993
50-day SMA
Sell
Level
$77.78
MACD (12, 26)
Sell
Level
-1.30
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
130.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7678)
Buy
CA Score
(Annual)
Level (-0.1353)
Buy
Beneish M-Score
(Annual)
Level (-2.5388)
Sell
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.6864)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
Stock Forecast FAQ
In the current month, TKR has received 5 Buy ratings 6 Hold ratings, and 0 Sell ratings. The TKR average analyst price target in the past 3 months is $91.20.
-
Where Will The Timken Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Timken share price will rise to $91.20 per share over the next 12 months.
-
What Do Analysts Say About The Timken?
Analysts are divided on their view about The Timken share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Timken is a Sell and believe this share price will drop from its current level to $77.00.
-
What Is The Timken's Price Target?
The price target for The Timken over the next 1-year time period is forecast to be $91.20 according to 11 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is TKR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Timken is a Hold. 6 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TKR?
You can purchase shares of The Timken via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Timken shares.
-
What Is The The Timken Share Price Today?
The Timken was last trading at $74.26 per share. This represents the most recent stock quote for The Timken. Yesterday, The Timken closed at $74.18 per share.
-
How To Buy The Timken Stock Online?
In order to purchase The Timken stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
